Publications by authors named "Jan Hoflack"

Claim this Profile
D
Development of small macrocyclic kinase inhibitors.
Jin Ma, Gonzalo Sanchez-Duffhues, Josselin Caradec, Pascal Benderitter, Jan Hoflack

Future Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors.
Jin Ma, Jiang Ren, Midory Thorikay, Maarten van Dinther, Gonzalo Sanchez-Duffhues, Jan Hoflack

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells.
Gonzalo Sánchez-Duffhues, Eleanor Williams, Pascal Benderitter, Valeria Orlova, Michiel van Wijhe, Jan Hoflack

JBMR Plus· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.
Justine T Tigno-Aranjuez, Pascal Benderitter, Frederik Rombouts, Frederik Deroose, XiaoDong Bai, Jan Hoflack

J Biol Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REALISIS: a medicinal chemistry-oriented reagent selection, library design, and profiling platform.
Aziz Yasri, Didier Berthelot, Harry Gijsen, Theo Thielemans, Patrick Marichal, Jan Hoflack

J Chem Inf Comput Sci· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis